Rallybio
RLYB
32 hedge funds and large institutions have $63.3M invested in Rallybio in 2026 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 8 closing their positions.
29% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 7
7.56% less ownership
Funds ownership: 76.85% → 69.29% (-7.6%)
14% less funds holding
Funds holding: 37 → 32 (-5)
63% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 8
82% less capital inflows, than outflows
Capital inflows: $1.33M | Capital outflows: $7.51M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Investments
New York
|
+$439K |
| 2 |
Spark Investment Management
New York
|
+$210K |
| 3 |
Morgan Stanley
New York
|
+$181K |
| 4 |
Vanguard Fiduciary Trust
Malvern,
Pennsylvania
|
+$149K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$135K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Nantahala Capital Management
New Canaan,
Connecticut
|
-$3.01M |
| 2 |
Almitas Capital
Santa Monica,
California
|
-$1.93M |
| 3 |
Renaissance Technologies
New York
|
-$891K |
| 4 |
Jane Street
New York
|
-$411K |
| 5 |
HRT Financial
New York
|
-$410K |
RLYB Hedge Fund Activity: Q3 2026 in Review
32 of the 8,184 institutional investors tracked by Wall St. Rank reported a position in Rallybio (RLYB) for Q3 2026, worth a combined $63.3M — down 2.7% from $65M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of RLYB and 3 opened new positions — a net loss of 5 holders — while 7 trimmed existing stakes and 9 added.
The largest buyer was Two Sigma Investments, adding an estimated $439K. The largest seller was Nantahala Capital Management, exiting entirely with an estimated $3.01M sold.
- 32 institutional investors held Rallybio (RLYB) as of Q3 2026, down from 37 in Q2 2026.
- Funds reported $63.3M of Rallybio stock for Q3 2026, down 2.7% quarter-over-quarter.
- 3 funds opened new Rallybio positions in Q3 2026 and 8 closed out, a net change of -5 holders.
- The largest Rallybio buyer in Q3 2026 was Two Sigma Investments, an estimated $439K added.
- The largest Rallybio seller in Q3 2026 was Nantahala Capital Management, an estimated $3.01M sold.
Based on aggregated 13F filings for Q3 2026.